Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Howlader N, Altekruse SF, Li CI, Chen VW, Clarke CA, Ries LA, Cronin KA (2014) US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst.
https://doi.org/10.1093/jnci/dju055
2. Goddard KA, Weinmann S, Richert-Boe K, Chen C, Bulkley J, Wax C (2012) HER2 evaluation and its impact on breast cancer treatment decisions. Public Health Genomics 15(1):1–10.
https://doi.org/10.1159/000325746
3. US Food and Drug Administration (2018) Herceptin prescribing information.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103792s5345lbl.pdf
4. US Food and Drug Administration (2019) Kadcyla prescribing information.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125427s105lbl.pdf
5. US Food and Drug Administration (2017) Nerlynx prescribing information.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208051s000lbl.pdf
Cited by
61 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献